The New Paths to Market in Digital Health
We are seeing a revolution in how digital health companies distribute their product. Some are finding bottom up traction with end consumers as a path to enterprise buyer. Others are pioneering risk-based contracting, developing two-sided marketplaces, or taking advantage of new aggregator partnerships. a16z general partner Julie Yoo explains why the go-to-market (GTM) for digital health startups is shifting and the five new GTM motions that she sees emerging.
Read More
Risk-based Contracting for Value-based Care, a Founder’s Playbook
Healthcare is undergoing a transformation, from care that is predominately fee for service and based on volume to value-based care. Risk-based contracts are critical to building businesses based on risk and value, rather than fees and volume. We talked to digital health builders — from Firefly Health, Pearl Health, Waymark, Carrum Health, Eleanor Health, Patina Health, and BlueCross BlueShield of North Carolina — about deciding to go at risk, picking and negotiating with payor partners, defining success, and more.
B2C2B in Digital Health, a founder's playbook
A wave of digital health companies have entered the market by first going direct to consumers, clinicians, care providers, and even life science researchers (B2C). Once they have enough traction with a cohort of users, they start selling to the enterprise. We interviewed some of the most successful B2C2B digital health founders and leaders to put together a playbook for going bottom up.
a16z Bio on Clubhouse
Conversations with bold entrepreneurs and builders who are reimagining healthcare and biotech.
Follow a16z Bio club »-
a16z Bio #20: How useful is real world data in medicine?
a16z Bio General Partner and practicing physician Vineeta Agarwala talks to data initiative leaders from the University of California, Truveta, Foundation Medicine, and Johns Hopkins about how they are using real world data and how this data may be changing the role of academic medical centers (AMC) and other organizational players in our healthcare system.
-
a16z Bio #19 Going B2C2B in Digital Health
Digital health companies are finding new paths to market. In this special edition of the a16z bio show, recorded live at the HLTH conference in Boston, Julie Yoo and Jay Rughani talk to digital health builders from Maven, Butterfly, and Bold about one of these new go-to-market (GTM) motions: B2C2B, or bottom up.
-
a16z Bio #16 Digital Health for Complex Care
With Venkat Mocherla, Vijay Pande, Manav Sevak, Vineeta Agarwala, Sachin Jain, Tarun Kapoor, Rebecca Harrington
-
a16z Bio #13 Care After COVID with Accolade
With Vijay Pande, Vineeta Agarwala, Shantanu Nundy, Jorge Conde, Julie Yoo
-
a16z Bio #12 Talking Price Transparency and Patient Engagement with Cedar
With Florian Otto, Scott Kupor, Venkat Mocherla, Jorge Conde, Julie Yoo
-
a16z Bio #11 The Digital Health OGs with Ginger, Omada, and more
With Vineeta Agarwala, Karan Singh, Chris Hogg, Jorge Conde, Sean Duffy, Julie Yoo
-
a16z Bio #10 The Digital Health Difference with Lyra Health
With Vineeta Agarwala, Connie Chen, Jorge Conde, Julie Yoo
-
a16z Bio #5 From COVID to Consumerism & the Future of Virtual First Care
With Vijay Pande, Venkat Mocherla, Vineeta Agarwala, Stephen Klasko, Julie Yoo, Jorge Conde
-
a16z Bio #3 Metabolic Health with Levels
With Vijay Pande, Vineeta Agarwala, Jeff Jordan, Jorge Conde, Casey Means, Julie Yoo
-
a16z Bio #2 Digital Diagnostics
With Vijay Pande, Vineeta Agarwala, Gaurav Singal, Jorge Conde
-
a16z Bio #1 Things That Make You Go Hmmmm in Healthcare
With Vijay Pande, Vineeta Agarwala, Marc Andreessen, Jorge Conde, Nikhil Krishnan, Julie Yoo